Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. (Q39171689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

1 reference

management implication

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Kenneth H Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Eileen M. O'Reilly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Angel Mier Hicks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Joanne Chou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Marinela Capanu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

7 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

Clinical Colorectal Cancer

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

360-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms

3 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Exosomes: Potent regulators of tumor malignancy and potential bio-tools in clinical application

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites: pathophysiology and treatment.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Management of ascites due to gastrointestinal malignancy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Ascites: diagnosis and management

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Treatment of malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Review article: Management of ascites and associated complications in patients with cirrhosis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Medical and palliative management of malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Palliation of malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites: systematic review and guideline for treatment.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

The current and future management of malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites: new concepts in pathophysiology, diagnosis, and management

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Peritoneovenous shunts for palliation of the patient with malignant ascites

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Current and future options in the treatment of malignant ascites in ovarian cancer.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Radiological insertion and management of peritoneovenous shunt

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites: a 2-year review from a teaching hospital

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Prognostic significance of new onset ascites in patients with pancreatic cancer

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Pancreatic cancer with malignant ascites: clinical features and outcomes.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Malignant ascites symptom cluster in patients referred for paracentesis

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5099112

Palliation of malignant ascites

21 August 2018

1 reference

12 December 2020

1 reference

12 December 2020

[Ascites due to portal hypertension from breast cancer- related metastatic liver infiltration]

1 reference

12 December 2020

Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites

1 reference

12 December 2020

Comparison of percutaneous management techniques for recurrent malignant ascites

1 reference

12 December 2020

A survey of practice in management of malignant ascites

1 reference

12 December 2020

Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites

1 reference

12 December 2020

A comparative study of telomerase activity and cytologic diagnosis in malignant ascites

1 reference

12 December 2020

Pleurx tunneled catheter in the management of malignant ascites

1 reference

12 December 2020

A survey of current practice in the management of recurrent malignant ascites among oncologists and palliative-care physicians in the UK

1 reference

12 December 2020

Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA

1 reference

12 December 2020

The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis

1 reference

12 December 2020

10.1016/J.CLCC.2016.04.014

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27262896%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

27262896

1 reference